Belite Bio's, Tinlarebant, targets eye diseases STGD1 and GA, showing promising results but with delayed phase 3 trial data.

Merck's (MRK) new injectable version of Keytruda aims to overcome regulatory hurdles and market challenges, offering a more ...

For almost ten years, the MOMS program has helped dozens of women and their partners to rebuild their lives, stay sober and ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

Organizations join forces to create more mental health services in New Orleans, aided by a grant from the United Way.

“People would sit in my chair, and any hairdresser… knows, that’s like therapy. And people are heavy, they’re carrying around ...

Kennedy is Trump’s pick for health secretary, but he has a history of spreading misinformation about a range of issues.

In the past, when someone was sentenced to substance-use-disorder (SUD) treatment in lieu of jail time in connection with ...

Public health groups are challenging Roche's attempt to block a generic version of its expensive Spinal Muscular Atrophy drug, Risdiplam. They argue that Roche's patent infringement lawsuit ...

The origins of autoimmune diseases like it are often mysterious, and an immune system that sees the body it inhabits as an ...

Jordan Stephens outlines his battles with drug abuse, fame and grief in his new ... hours after arriving at university to begin her degree. The use of crack cocaine increased by 594% in Ireland ...